Literature DB >> 12598158

Population stratification and spurious allelic association.

Lon R Cardon1, Lyle J Palmer.   

Abstract

Great efforts and expense have been expended in attempts to detect genetic polymorphisms contributing to susceptibility to complex human disease. Concomitantly, technology for detection and scoring of single nucleotide polymorphisms (SNPs) has undergone rapid development, extensive catalogues of SNPs across the genome have been constructed, and SNPs have been increasingly used as a means for investigation of the genetic causes of complex human diseases. For many diseases, population-based studies of unrelated individuals--in which case-control and cohort studies serve as standard designs for genetic association analysis--can be the most practical and powerful approach. However, extensive debate has arisen about optimum study design, and considerable concern has been expressed that these approaches are prone to population stratification, which can lead to biased or spurious results. Over the past decade, a great shift has been noted, away from case-control and cohort studies, towards family-based association designs. These designs have fewer problems with population stratification but have greater genotyping and sampling requirements, and data can be difficult or impossible to gather. We discuss past evidence for population stratification on genotype-phenotype association studies, review methods to detect and account for it, and present suggestions for future study design and analysis.

Entities:  

Mesh:

Year:  2003        PMID: 12598158     DOI: 10.1016/S0140-6736(03)12520-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  391 in total

1.  Mapping genes that predict treatment outcome in admixed populations.

Authors:  T M Baye; R A Wilke
Journal:  Pharmacogenomics J       Date:  2010-10-05       Impact factor: 3.550

2.  Contribution of the IBD5 locus to inflammatory bowel disease: a meta-analysis.

Authors:  Jian Wang; Xi Wang; Hong Yang; Dong Wu; Li Wang; Jiaming Qian
Journal:  Hum Genet       Date:  2011-01-30       Impact factor: 4.132

3.  Matching strategies for genetic association studies in structured populations.

Authors:  David A Hinds; Renee P Stokowski; Nila Patil; Karel Konvicka; David Kershenobich; David R Cox; Dennis G Ballinger
Journal:  Am J Hum Genet       Date:  2004-01-21       Impact factor: 11.025

4.  Freely associating with chemokine receptor 2 polymorphisms and atherosclerosis.

Authors:  F C Luft
Journal:  J Mol Med (Berl)       Date:  2003-06       Impact factor: 4.599

5.  Control of confounding of genetic associations in stratified populations.

Authors:  Clive J Hoggart; Eteban J Parra; Mark D Shriver; Carolina Bonilla; Rick A Kittles; David G Clayton; Paul M McKeigue
Journal:  Am J Hum Genet       Date:  2003-06       Impact factor: 11.025

Review 6.  "Are we there yet?": Deciding when one has demonstrated specific genetic causation in complex diseases and quantitative traits.

Authors:  Grier P Page; Varghese George; Rodney C Go; Patricia Z Page; David B Allison
Journal:  Am J Hum Genet       Date:  2003-09-17       Impact factor: 11.025

Review 7.  Integrating ethics and science in the International HapMap Project.

Authors: 
Journal:  Nat Rev Genet       Date:  2004-06       Impact factor: 53.242

8.  WNT3A gene polymorphisms are associated with bone mineral density variation in postmenopausal mestizo women of an urban Mexican population: findings of a pathway-based high-density single nucleotide screening.

Authors:  Rafael Velázquez-Cruz; Humberto García-Ortiz; Manuel Castillejos-López; Manuel Quiterio; Margarita Valdés-Flores; Lorena Orozco; Teresa Villarreal-Molina; Jorge Salmerón
Journal:  Age (Dordr)       Date:  2014-03-03

9.  The Implications of Genetics for Prevention and Intervention Programming.

Authors:  Rashelle J Musci; Gabriel Schlomer
Journal:  Prev Sci       Date:  2018-01

Review 10.  Pharmacogenetics and smoking cessation with nicotine replacement therapy.

Authors:  Riju Ray; Robert A Schnoll; Caryn Lerman
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.